{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:30:20Z","timestamp":1792636220999,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2021IP0059-1"],"award-info":[{"award-number":["2021IP0059-1"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2021IP0061-1"],"award-info":[{"award-number":["2021IP0061-1"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["9991006821"],"award-info":[{"award-number":["9991006821"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["KMDF_PR_20200901_0148"],"award-info":[{"award-number":["KMDF_PR_20200901_0148"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HH21C0012"],"award-info":[{"award-number":["HH21C0012"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10103-021-03482-z","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T19:03:47Z","timestamp":1642014227000},"page":"2185-2192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of intense pulsed light using acne filter on eyelid margin telangiectasia in moderate-to-severe meibomian gland dysfunction"],"prefix":"10.1007","volume":"37","author":[{"given":"Jung Yeob","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyu","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-6580","authenticated-orcid":false,"given":"Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hungwon","family":"Tchah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"4","key":"3482_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","volume":"52","author":"E Knop","year":"2011","unstructured":"Knop E, Knop N, Millar T, Obata H, Sullivan DA (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 52(4):1938\u20131978","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3482_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3341\/kjo.2018.0104","volume":"33","author":"Y Eom","year":"2019","unstructured":"Eom Y, Na KS, Cho KJ, Hwang HS, Kim SW, Chung TY et al (2019) Distribution and characteristics of meibomian gland dysfunction subtypes: a multicenter study in South Korea. Korean J Ophthalmol 33(3):205\u2013213","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"3482_CR3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","volume":"52","author":"JD Nelson","year":"2011","unstructured":"Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S et al (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52(4):1930\u20131937","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3482_CR4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1136\/bjo.86.12.1403","volume":"86","author":"E Goto","year":"2002","unstructured":"Goto E, Monden Y, Takano Y, Mori A, Shimmura S, Shimazaki J et al (2002) Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol 86(12):1403\u20131407","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3482_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjophthalmol-2012-302668","volume":"97","author":"R Arita","year":"2013","unstructured":"Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H et al (2013) Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol 97(6):725\u2013729","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"3482_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/ICO.0000000000002243","volume":"39","author":"IJ Epstein","year":"2020","unstructured":"Epstein IJ, Rosenberg E, Stuber R, Choi MB, Donnenfeld ED, Perry HD (2020) Double-masked and unmasked prospective study of terpinen-4-ol lid scrubs with microblepharoexfoliation for the treatment of demodex blepharitis. Cornea 39(4):408\u2013416","journal-title":"Cornea"},{"issue":"4","key":"3482_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICO.0000000000002235","volume":"39","author":"J Tauber","year":"2020","unstructured":"Tauber J (2020) A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction. Cornea 39(4):403\u2013407","journal-title":"Cornea"},{"issue":"6","key":"3482_CR8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ajo.2014.08.015","volume":"158","author":"H Lee","year":"2014","unstructured":"Lee H, Chung B, Kim KS, Seo KY, Choi BJ, Kim TI (2014) Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial. Am J Ophthalmol 158(6):1172-1183.e1171","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"3482_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","volume":"154","author":"H Lee","year":"2012","unstructured":"Lee H, Min K, Kim EK, Kim TI (2012) Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction. Am J Ophthalmol 154(6):949-957.e941","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"3482_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/cxo.12532","volume":"100","author":"H Lee","year":"2017","unstructured":"Lee H, Kim M, Park SY, Kim EK, Seo KY, Kim TI (2017) Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction. Clin Exp Optom 100(6):598\u2013602","journal-title":"Clin Exp Optom"},{"issue":"4","key":"3482_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","volume":"19","author":"SE Yoo","year":"2005","unstructured":"Yoo SE, Lee DC, Chang MH (2005) The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 19(4):258\u2013263","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"3482_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ophtha.2015.10.011","volume":"123","author":"JP Lienert","year":"2016","unstructured":"Lienert JP, Tarko L, Uchino M, Christen WG, Schaumberg DA (2016) Long-term natural history of dry eye disease from the patient\u2019s perspective. Ophthalmology 123(2):425\u2013433","journal-title":"Ophthalmology"},{"issue":"3","key":"3482_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","volume":"11","author":"M Alves","year":"2013","unstructured":"Alves M, Fonseca EC, Alves MF, Malki LT, Arruda GV, Reinach PS et al (2013) Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf 11(3):181\u2013192","journal-title":"Ocul Surf"},{"issue":"1","key":"3482_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12886-021-01926-2","volume":"21","author":"SY Moon","year":"2021","unstructured":"Moon SY, Han SA, Kwon HJ, Park SY, Lee JH, Chung HS et al (2021) Effects of lid debris debridement combined with meibomian gland expression on the ocular surface MMP-9 levels and clinical outcomes in moderate and severe meibomian gland dysfunction. BMC Ophthalmol 21(1):175","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"3482_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/pho.2014.3819","volume":"33","author":"R Toyos","year":"2015","unstructured":"Toyos R, McGill W, Briscoe D (2015) Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg 33(1):41\u201346","journal-title":"Photomed Laser Surg"},{"issue":"4","key":"3482_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/ICU.0000000000000166","volume":"26","author":"GK Vora","year":"2015","unstructured":"Vora GK, Gupta PK (2015) Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol 26(4):314\u2013318","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"3482_CR17","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1167\/iovs.14-15764","volume":"56","author":"JP Craig","year":"2015","unstructured":"Craig JP, Chen YH, Turnbull PR (2015) Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 56(3):1965\u20131970","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3482_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","volume":"17","author":"R Arita","year":"2019","unstructured":"Arita R, Fukuoka S, Morishige N (2019) Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf 17(1):104\u2013110","journal-title":"Ocul Surf"},{"issue":"2","key":"3482_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/lsm.10145","volume":"32","author":"C Raulin","year":"2003","unstructured":"Raulin C, Greve B, Grema H (2003) IPL technology: a review. Lasers Surg Med 32(2):78\u201387","journal-title":"Lasers Surg Med"},{"key":"3482_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2147\/OPTH.S139894","volume":"11","author":"SJ Dell","year":"2017","unstructured":"Dell SJ (2017) Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol 11:1167\u20131173","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3482_CR21","doi-asserted-by":"publisher","first-page":"101339","DOI":"10.1016\/j.clae.2020.05.008","volume":"44","author":"H Lee","year":"2021","unstructured":"Lee H, Han YE, Park SY, Lee JH, Chung HS, Moon SY et al (2021) Changes in the expression of matrix metalloproteinase-9 after intense pulsed light therapy combined with meibomian gland expression in moderate and severe meibomian gland dysfunction. Cont Lens Anterior Eye 44(3):101339","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"3482_CR22","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","volume":"52","author":"KK Nichols","year":"2011","unstructured":"Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K et al (2011) The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 52(4):1922\u20131929","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3482_CR23","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","volume":"52","author":"A Tomlinson","year":"2011","unstructured":"Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI et al (2011) The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 52(4):2006\u20132049","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3482_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.det.2009.08.006","volume":"27","author":"WE Roberts","year":"2009","unstructured":"Roberts WE (2009) Skin type classification systems old and new. Dermatol Clin 27(4):529\u2013533","journal-title":"Dermatol Clin"},{"issue":"12","key":"3482_CR25","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1097\/ICO.0000000000001687","volume":"37","author":"R Arita","year":"2018","unstructured":"Arita R, Mizoguchi T, Fukuoka S, Morishige N (2018) Multicenter study of intense pulsed light therapy for patients with refractory meibomian gland dysfunction. Cornea 37(12):1566\u20131571","journal-title":"Cornea"},{"issue":"1","key":"3482_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2013-203845","volume":"73","author":"A Rasmussen","year":"2014","unstructured":"Rasmussen A, Ice JA, Li H, Grundahl K, Kelly JA, Radfar L et al (2014) Comparison of the American-European Consensus Group Sjogren\u2019s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73(1):31\u201338","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3482_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S et al (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren\u2019s Syndrome International Registry. Am J Ophthalmol 149(3):405\u2013415","journal-title":"Am J Ophthalmol"},{"key":"3482_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajo.2016.06.025","volume":"169","author":"R Arita","year":"2016","unstructured":"Arita R, Minoura I, Morishige N, Shirakawa R, Fukuoka S, Asai K et al (2016) Development of definitive and reliable grading scales for meibomian gland dysfunction. Am J Ophthalmol 169:125\u2013137","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"3482_CR29","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/archopht.1995.01100100054027","volume":"113","author":"J Shimazaki","year":"1995","unstructured":"Shimazaki J, Sakata M, Tsubota K (1995) Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 113(10):1266\u20131270","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"3482_CR30","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1167\/iovs.10-6997d","volume":"52","author":"KB Green-Church","year":"2011","unstructured":"Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S et al (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 52(4):1979\u20131993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3482_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1444-0938.2011.00634.x","volume":"95","author":"U Stahl","year":"2012","unstructured":"Stahl U, Willcox M, Stapleton F (2012) Osmolality and tear film dynamics. Clin Exp Optom 95(1):3\u201311","journal-title":"Clin Exp Optom"},{"issue":"3","key":"3482_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0181-5512(07)89584-2","volume":"30","author":"C Baudouin","year":"2007","unstructured":"Baudouin C (2007) A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol 30(3):239\u2013246","journal-title":"J Fr Ophtalmol"},{"issue":"11","key":"3482_CR33","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.1167\/iovs.14-15512","volume":"55","author":"P Mudgil","year":"2014","unstructured":"Mudgil P (2014) Antimicrobial role of human meibomian lipids at the ocular surface. Invest Ophthalmol Vis Sci 55(11):7272\u20137277","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3482_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1167\/iovs.11-8551","volume":"53","author":"D Borchman","year":"2012","unstructured":"Borchman D, Foulks GN, Yappert MC, Milliner SE (2012) Differences in human meibum lipid composition with meibomian gland dysfunction using NMR and principal component analysis. Invest Ophthalmol Vis Sci 53(1):337\u2013347","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3482_CR35","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1167\/iovs.07-0588","volume":"48","author":"JE Graham","year":"2007","unstructured":"Graham JE, Moore JE, Jiru X, Moore JE, Goodall EA, Dooley JS et al (2007) Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci 48(12):5616\u20135623","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3482_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Benitez-del-Castillo J et al (2016) Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol 100(3):300\u2013306","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3482_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtos.2020.01.003","volume":"18","author":"AL Xue","year":"2020","unstructured":"Xue AL, Wang MTM, Ormonde SE, Craig JP (2020) Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf 18(2):286\u2013297","journal-title":"Ocul Surf"},{"issue":"8","key":"3482_CR38","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s10103-017-2317-4","volume":"32","author":"C Ash","year":"2017","unstructured":"Ash C, Dubec M, Donne K, Bashford T (2017) Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med Sci 32(8):1909\u20131918","journal-title":"Lasers Med Sci"},{"key":"3482_CR39","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2147\/DDDT.S146556","volume":"12","author":"X Jiang","year":"2018","unstructured":"Jiang X, Wang Y, Lv H, Liu Y, Zhang M, Li X (2018) Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. Drug Des Devel Ther 12:1269\u20131279","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3482_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/ICO.0b013e3182541e9a","volume":"32","author":"HE Kaufman","year":"2013","unstructured":"Kaufman HE (2013) The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Cornea 32(2):211\u2013216","journal-title":"Cornea"},{"issue":"7","key":"3482_CR41","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1167\/iovs.08-2476","volume":"50","author":"S Chotikavanich","year":"2009","unstructured":"Chotikavanich S, de Paiva CS, de Li Q, Chen JJ, Bian F, Farley WJ et al (2009) Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 50(7):3203\u20133209","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3482_CR42","doi-asserted-by":"publisher","first-page":"3143469","DOI":"10.1155\/2019\/3143469","volume":"2019","author":"F Ruan","year":"2019","unstructured":"Ruan F, Zang Y, Sella R, Lu H, Li S, Yang K et al (2019) Intense pulsed light therapy with optimal pulse technology as an adjunct therapy for moderate to severe blepharitis-associated keratoconjunctivitis. J Ophthalmol 2019:3143469","journal-title":"J Ophthalmol"},{"issue":"5","key":"3482_CR43","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11596-019-2108-1","volume":"39","author":"SN Cheng","year":"2019","unstructured":"Cheng SN, Jiang FG, Chen H, Gao H, Huang YK (2019) Intense pulsed light therapy for patients with meibomian gland dysfunction and ocular demodex infestation. Curr Med Sci 39(5):800\u2013809","journal-title":"Curr Med Sci"},{"issue":"1","key":"3482_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1529-8019.2010.01382.x","volume":"24","author":"OA Ibrahimi","year":"2011","unstructured":"Ibrahimi OA, Avram MM, Hanke CW, Kilmer SL, Anderson RR (2011) Laser hair removal. Dermatol Ther 24(1):94\u2013107","journal-title":"Dermatol Ther"},{"issue":"Suppl 3","key":"3482_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/bjd.12526","volume":"169","author":"AF Alexis","year":"2013","unstructured":"Alexis AF (2013) Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol 169(Suppl 3):91\u201397","journal-title":"Br J Dermatol"},{"issue":"4","key":"3482_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IOP.0b013e31820c6e23","volume":"27","author":"WW Lee","year":"2011","unstructured":"Lee WW, Murdock J, Albini TA, O\u2019Brien TP, Levine ML (2011) Ocular damage secondary to intense pulse light therapy to the face. Ophthalmic Plast Reconstr Surg 27(4):263\u2013265","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"9","key":"3482_CR47","first-page":"1276","volume":"34","author":"AL Pang","year":"2008","unstructured":"Pang AL, Wells K (2008) Bilateral anterior uveitis after intense pulsed light therapy for pigmented eyelid lesions. Dermatol Surg 34(9):1276\u20131279","journal-title":"Dermatol Surg"},{"issue":"9","key":"3482_CR48","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/j.1524-4725.2010.01661.x","volume":"36","author":"G Javey","year":"2010","unstructured":"Javey G, Schwartz SG, Albini TA (2010) Ocular complication of intense pulsed light therapy: iris photoablation. Dermatol Surg 36(9):1466\u20131468","journal-title":"Dermatol Surg"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-021-03482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-021-03482-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-021-03482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T05:07:55Z","timestamp":1653714475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-021-03482-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3482"],"URL":"https:\/\/doi.org\/10.1007\/s10103-021-03482-z","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki. The Ethics Committee of Asan Medical Center (Seoul, Republic of Korea) approved the study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was waived for this study given its retrospective design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was waived for this study given its retrospective design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}